Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Chatzaki, E.
Right arrow Articles by Gravanis, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chatzaki, E.
Right arrow Articles by Gravanis, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 6, No. 7, 602-609, July 2000
© 2000 European Society of Human Reproduction and Embryology

Uterine physiology

Kappa opioids and TGFß1 interact in human endometrial cells

E. Chatzaki1, A.N. Margioris2, A. Makrigiannakis1, E. Castanas3, V. Georgoulias4 and A. Gravanis1,5

1 Department of Pharmacology, 2 Department of Clinical Chemistry, 3 Department of Experimental Endocrinology and 4 Department of Oncology, Medical School, University of Crete, Heraklion GR-711 10, Crete, Greece

Abstract

The transforming growth factor ß1 (TGFß1) is a major regulator of human endometrial function. Human endometrium possesses specific opioid binding sites, the majority of which belong to the kappa type, for which the prodynorphin-derived opioids are the endogenous ligands. Since these two systems interact in several other tissues we postulated that opioids may affect the production of TGFß1 in human endometrium. We have found that kappa opioids exerted a time- and dose-dependent inhibitory effect on TGFß1 production from endometrial stromal and epithelial cells and from the Ishikawa human endometrial adenocarcinoma cell line. This effect was reversible by the specific opioid antagonist diprenorphine. To examine if this effect represents a paracrine endometrial response to locally produced kappa opioids we searched for the presence of the endogenous kappa opioid receptor ligands. Indeed, the prodynorphin transcript was detectable on Northern blots from normal and tumoral human endometrial cells; its size was that of the pituitary transcript, i.e. ~2.4 kb long. Most immunoreactive dynorphin from human endometrium had a molecular weight of 8 kDa. Finally, immunofluorescence staining of normal and tumoral human endometrial cells revealed the presence of dynorphin-positive cytoplasmic secretory granules. Taken together, our data suggest that in human endometrium, kappa opioids and the TGFß1 form a paracrine network which appears to be retained by the Ishikawa human endometrial adenocarcinoma cell line.

dynorphins/endometrium/human/opioids/TGFß

Notes

5 To whom correspondence should be addressed at: Medical School, University of Crete, Heraklion 71110 Greece. E-mail: gravanis{at}med.voc.gr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Mol Hum ReprodHome page
E. Chatzaki, A. Makrigiannakis, A.N. Margioris, E. Kouimtzoglou, and A. Gravanis
The Fas/FasL apoptotic pathway is involved in {kappa}-opioid-induced apoptosis of human endometrial stromal cells
Mol. Hum. Reprod., September 1, 2001; 7(9): 867 - 874.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.